Arasal 2025: Backlog Is Rebuilding, but Earnings Still Depend on Control Systems

Company Overview

At first glance, Arasal can look like another small defense company riding a wave of new orders. That reading is too shallow. In practice, this is a 38-employee business with three very different economic engines under one roof: control systems for aircraft, muzzle velocity radars for artillery, and HUMS, the health-monitoring layer for airborne and industrial systems. In 2025, control systems carried the report. Muzzle velocity radars rebounded. HUMS, which had been the star of 2024, nearly disappeared from the top line and became the main drag on profitability.

What is working now is real customer access. In 2025, the U.S. Air Force accounted for 33% of sales, another U.S. customer group that the company identifies as Lockheed Martin and others accounted for 16%, and HAL in India contributed another 13%. This is not paper backlog alone. It is a position inside active defense programs. The post-balance-sheet order flow from January through March 2026 reinforces that point.

What is still messy is the quality of the earnings base. The 2025 report makes clear that backlog alone does not tell the full story. HUMS fell from NIS 22.2 million of revenue to just NIS 2.1 million, flipping from NIS 9.4 million of operating profit to an operating loss of NIS 7.2 million. Anyone looking only at the backlog expansion is missing the core issue: the longer-dated technology layer still has not proved that it can convert into recurring profit.

Arasal’s active bottleneck is not factory capacity. The company relies heavily on subcontractors, while final assembly and testing remain in-house. According to the report, existing capacity can scale materially without significant new infrastructure investment. The bottleneck sits elsewhere: order timing, product mix, and the move from a backlog story built on awards and promises to a profit story built on actual delivery.

The 2025 economic map is straightforward:

The company ended the year with NIS 41.3 million of revenue. Against a workforce of 38 employees, that implies revenue per employee of roughly NIS 1.1 million. This is not a large platform, which means every meaningful order, every delay, and every change in customer mix can move the numbers sharply.

Events And Triggers

The main trigger around Arasal right now is simple: backlog is rebuilding faster than earnings. Year-end consolidated backlog stood at NIS 74.9 million, up from NIS 35.9 million at the end of 2024. Near the publication date, it had already risen to NIS 87.0 million. That is a major jump, but it needs to be unpacked. Most of the improvement came from control systems and MVR. HUMS remained at NIS 21.5 million of backlog, unchanged versus year-end, and most of that still sits in 2027 and beyond.

The first trigger: continued order flow after the balance sheet date. On January 9, 2026, the company received a $1.2 million order for maintenance and upgrades of J85 engine control systems for the U.S. Air Force, as the second-year option exercise within a $6 million five-year framework agreement. On February 18, another roughly $517 thousand order came from the same customer, with company guidance pointing to a further roughly $700 thousand order during 2026 and a separate potential $2.8 million order for new J85 controllers. This is no longer abstract backlog. It is a thickening revenue pipeline around an anchor customer.

The second trigger: a widening order stream in control systems and MVR. On February 20, the company reported an order of roughly NIS 4 million for an electrical power controller for an aircraft, including a 30% upfront payment and delivery in the second half of 2026. On March 9, it added an order of roughly $581 thousand for an energy distribution, management, and control system for an unmanned aircraft, with about 60% scheduled for 2026 delivery and the balance in February 2027. On January 22, the company also reported a $275 thousand order for an automatic test station for an MVR customer in India, and on March 18 another $395 thousand for test equipment tied to the emergency power system of the F-16.

The third trigger: the Lockheed Martin order from March 24, 2026. Financially it is small, roughly $260 thousand. Strategically it matters more. The company says this is the first time it has been selected as part of the development of a brake controller for a new aircraft, unlike most of its prior work, which focused on retrofits and upgrades of existing platforms. This is not yet proven commercial scale, but it does move the company from retrofit work toward design-in exposure.

The fourth trigger: the post-balance-sheet dividend. The company approved a NIS 7.5 million distribution after year-end. That is not a side detail. It is an active choice to pull cash out of the business at the same time management is asking the market to trust that the rebuilt backlog will convert into profit.

The number that matters is not only NIS 87 million. What matters more is what sits inside it. Control systems alone rose from NIS 35.7 million of backlog to NIS 44.6 million, while MVR rose from NIS 17.7 million to NIS 21.0 million. HUMS, the business line management frames as a key technology direction, did not show a similar step-up.

Efficiency, Profitability, And Competition

Who Actually Carried 2025

The decisive number in the report is that control systems almost single-handedly carried the company. The segment generated NIS 26.8 million of revenue and NIS 17.9 million of gross profit, compared with NIS 28.7 million and NIS 11.4 million in 2024. In other words, revenue eased slightly, but earnings quality improved materially. Segment operating profit rose to NIS 13.7 million from NIS 8.4 million.

MVR delivered the second positive surprise. Revenue rose to NIS 12.4 million from NIS 3.1 million in 2024, while the segment turned to a positive NIS 0.5 million operating profit after a NIS 1.0 million operating loss in the prior year. This shows the business is not relying only on service and upgrade work for legacy aircraft systems. It also has an artillery leg that is reaccelerating, mainly through India and new or upgraded gun programs.

HUMS is the big yellow flag in the 2025 report. Revenue fell 91%, from NIS 22.2 million to NIS 2.1 million. Gross profit flipped from NIS 16.0 million to negative NIS 4.0 million, and operating profit fell from NIS 9.4 million to a NIS 7.2 million loss. So anyone telling themselves a simple story about Arasal as a HUMS growth company is not really reading the report. In 2025, this was not a HUMS earnings story. It was a control-systems company with an open HUMS option.

Why The Top Line Fell Without Proving That The Whole Business Weakened

Revenue fell 24% to NIS 41.3 million. Gross profit dropped 42% to NIS 16.8 million. Operating profit fell 59% to NIS 7.0 million, and net income declined 66% to NIS 5.5 million. On the surface, this reads like a sharp deterioration. A more accurate reading is that 2024 was unusually strong, especially because of HUMS sales into the Far East. So 2025 is not necessarily a year in which the whole business weakened. It is a year in which mix reverted toward the current core engines.

That same pattern is visible in the second half, which is the latest disclosed run-rate. MVR rose to NIS 9.9 million from NIS 2.8 million in the prior-year half. Control systems fell to NIS 18.6 million from NIS 22.9 million, but remained strong. HUMS collapsed to NIS 1.9 million from NIS 21.6 million. So the rebound in the latest disclosed period is visible in only two segments, not all three.

The important nuance is that the company itself says the 2025 gross margin of roughly 41% reflects its more typical level, while 2024’s 54% margin was unusually high. That matters. It means the market cannot simply take 2024, spread it forward, and treat it as a steady base. The 2025 report forces a more disciplined read.

Competition And Where The Moat Is Real

Arasal does have a moat, but it is uneven across the segments. In MVR, the moat comes from long operating history, reliability, and compatibility across a broad range of gun systems and ammunition, with the company describing only a handful of global competitors and significant installed usage in Israel, the U.S., and India.

In control systems, the moat is less about scale and more about position inside the platform. Once the company sits inside a starter controller, brake controller, fuel controller, or J85 unit, replacing it is not trivial. The market is conservative, qualification paths are long, and the company benefits from a reputation built around Israeli Air Force and U.S. defense work.

In HUMS, the story is more complicated. There is technology, grant support, HAL-related programs, a smart sensor roadmap, and pilot work with Israel Railways. But there is also certification friction, long sales cycles, and reliance on large customers and partnerships. That is a potential moat, not yet a proven earnings moat.

Cash Flow, Debt, And Capital Structure

All-In Cash Flexibility: What Was Really Left After The Year’s Uses

The most misleading number in 2025 is cash flow. On one side, net income was NIS 5.5 million. On the other, operating cash flow jumped to NIS 23.4 million. That gap is huge, and it did not come from a surge in underlying earnings quality. It came mainly from working capital release. Receivables fell from NIS 40.0 million to NIS 20.5 million, meaning the company collected a large portion of balances that had built up in 2024.

That point matters because it determines which cash lens should be used. Here, the right frame is all-in cash flexibility, not a normalized version. The practical question around Arasal right now is not how much cash the business would generate in a cleaner steady state. It is how much real room remained after the actual uses of cash.

On that basis, NIS 23.4 million of operating cash flow looks much less roomy. During 2025, the company paid NIS 18.8 million of dividends, repaid NIS 1.57 million of lease obligations, and spent another NIS 145 thousand on fixed assets. In other words, most of the operating cash flow was used up. That does not mean the company is in distress. It does mean the year-end cash balance reflects a very aggressive distribution policy layered on top of a working-capital release rather than a new, deeper earnings base.

The Balance Sheet Looks Conservative, But Capital Allocation Pulls The Rope Tight

At year-end 2025, the company had NIS 5.2 million of cash and cash equivalents plus NIS 5.5 million of restricted deposits. The current ratio stood at 3.85. It had NIS 7 million of approved credit lines and was not drawing them. The main covenant is simple: tangible equity must not fall below 25% of total assets. With NIS 31.7 million of equity against a NIS 44.6 million balance sheet, the company sits far away from covenant stress.

The debt side is also fairly light. There is no meaningful drawn bank debt distorting the picture. Lease liabilities total NIS 2.9 million, of which NIS 1.48 million is current. The company re-leased its Migdal HaEmek facility and recognized a NIS 2.1 million right-of-use asset from the new lease. This matters, but it does not create a financing squeeze.

The issue is not the balance sheet. The issue is capital allocation. The company paid NIS 18.8 million of dividends in 2025, far above that year’s NIS 5.5 million of net income. After the dividend approved post-balance-sheet, the company says it would still have roughly NIS 2.7 million of distributable retained earnings left. That is not collapse. It is, however, evidence that the company chose to pull forward cash that was created mainly by collections, not by a newly rebuilt earnings base.

Forward View

Before looking ahead, four findings should be locked in:

• Backlog genuinely expanded, but most of the improvement sits in control systems and MVR, not in HUMS.
• The strong 2025 cash flow came mainly from collections, not from strong recurring earnings quality.
• The first Lockheed Martin order matters more strategically than financially because it opens an early position in a new aircraft program.
• The 2025 and early 2026 dividend policy raises the proof bar for the next set of results.

2026 currently looks like a proof year, not a breakout year. The company enters it with NIS 87.0 million of backlog near the report date, but only NIS 30.8 million of that backlog is scheduled for realization during 2026. That matters a great deal. 2025 revenue was NIS 41.3 million. So without additional orders and without faster program conversion, the backlog already scheduled into 2026 does not fully reproduce the prior year’s revenue level.

The second thing to watch is conversion quality. If the company turns the new control-system and MVR orders into revenue on time, 2026 should look better on the surface. But if conversion slips, or if mix tilts again toward lower-quality or delayed contribution, the market will quickly rediscover that a large backlog is not the same thing as durable earnings.

The third issue is HUMS. On one side, the company has an Israel Innovation Authority grant, advanced edge-processing development, HAL-related programs, and a smart-sensor roadmap. On the other side, 2025 already showed that the path from promise to commercialization is far from automatic. Until HUMS returns to a meaningful revenue base, it cannot carry the bullish read on its own.

The fourth issue is Lockheed Martin. The current order is small, but it is one of the more important checkpoints for the next 12 months. If this remains limited to prototype and simulation work, the contribution will stay modest. If it develops into a deeper position inside a new platform, the market will start to read Arasal differently.

Risks

The first risk is concentration. 85% of 2025 sales came from major customer groups. The U.S. Air Force alone represented 33% of sales, another U.S. customer group 16%, HAL another 13%, and key Israeli groups took a meaningful share as well. That is moat and dependency at the same time. When a major customer moves a program, the whole company feels it.

The second risk is backlog quality. HUMS backlog stands at NIS 21.5 million, but most of it sits in 2027 and beyond. At the same time, the segment ended 2025 with a gross loss and an operating loss. So that backlog cannot be read as if it were already earnings. It is still an option layer that needs conversion proof.

The third risk is FX. The company is mainly exposed to the U.S. dollar, and its own sensitivity analysis shows that a 10% move in the exchange rate changes profit by about NIS 1.87 million. Management does hedge part of the exposure through forward contracts, but FX can still distort how a single-year result is interpreted.

The fourth risk is capital allocation. There is no debt pressure at present, but there is a distribution policy that is moving cash out faster than annual earnings are rebuilding. If 2026 does not deliver more consistent earnings and cash flow, the heavy distributions will look overly aggressive in hindsight.

The fifth risk is knowledge concentration. The company explicitly states that much of its technological and engineering know-how sits with a small number of key people, some of them beyond retirement age. In a small company, knowledge loss is not abstract. It can delay development, upgrades, and service execution.

The sixth risk is regulation and supply chain. Defense exports depend on permits, and the company currently holds a defense marketing and export approval through October 30, 2026. It also flags lengthening lead times and rising component costs. In MVR it has qualified second and third suppliers for a key component, but that effort itself is a reminder that the supply chain remains sensitive.

Conclusions

Arasal ends 2025 in an interesting but still unclean place. What supports the thesis is a doubled backlog, a continuing order stream after the balance sheet date, and a control-systems segment that has shown it can generate real earnings. What weighs on the story is that HUMS still has not returned as an earnings engine, and that much of 2025’s cash strength came from collections rather than from a structurally stronger business. Over the short to medium term, the market is likely to react mainly to whether the early-2026 order flow converts into revenue without weakening profit quality and without stretching the cash position after distributions.

Current thesis: Arasal enters 2026 with proven demand and a stronger backlog, but the business still depends economically on control systems, while HUMS remains a long-dated option layer that has not yet shown repeatable earnings power.

What changed versus the prior understanding of the company? Mainly two things. First, MVR has become a growth engine again rather than just a legacy leg. Second, HUMS has moved from being a one-year earnings driver in 2024 back to being a future layer that requires proof again. The strongest counter-thesis is that this cautious reading misses a small company with unusually strong anchor customers, an NIS 87 million backlog, and a first foothold with Lockheed Martin on a new program. That is a serious argument. But it still needs 2026 numbers to validate it.

What could change the market reading over the short to medium term? First, tangible progress in the Lockheed Martin project and in follow-on work with the U.S. Air Force. Second, the actual revenue conversion pace of the new control-system and MVR orders. Third, any sign that HUMS is returning to reported sales rather than staying mostly in the zone of pilots, grants, and long-dated backlog. On the other hand, if cash keeps leaving through distributions faster than recurring earnings rebuild, even a high backlog will look less convincing.

This matters because Arasal has already proved that it can gain access to real programs and important customers. The open question is whether it can turn that access into a steadier earnings structure, rather than a sequence of unusual years and order headlines. For the thesis to strengthen over the next 2 to 4 quarters, the company needs orderly conversion of the new backlog into revenue, sustained control-systems margins, and a return of HUMS to positive economic contribution. What would weaken the thesis is delayed conversion, gross-margin slippage, or a payout policy that continues to front-load cash distributions at the expense of balance-sheet cushion.